Issuers and investment banks trust O’Melveny to help them successfully execute a broad spectrum of strategic and capital-raising transactions across a range of industries, including financial, health care, retail, technology, media, communications, real estate, and energy.
Our capital markets team has substantial experience running the most complicated and high-profile deals. We view challenges from all perspectives—companies, investment banks, and regulators—to navigate deals seamlessly from launch through pricing and closing. Our clients also benefit from the insight and experience of the many former high-ranking SEC officials at the firm, who advise on complex regulatory matters.
We help clients achieve a full spectrum of capital markets transactions, including:
Initial public offerings, secondary and follow-on stock offerings
Investment-grade and high-yield debt offerings
Convertible notes and other equity-linked securities offerings
Medium-term note programs
Liability management transactions, such as tender offers, exchange offers, consent solicitations, amendments and waivers
Spin-offs, split-offs and other carve-out transactions
Equity forwards and other complex derivative transactions
Rule 144A, Regulation S, Section 4(a)(2) / Regulation D, PIPEs and other unregistered offerings
At-the-market programs
Block trades and bought deals
Stock exchange listings
Air Lease Corp.
O’Melveny represented Air Lease, an aircraft leasing company, in a series of major financing transactions within a single year—three public offerings of debt, raising aggregate gross proceeds of US$1.85 billion; a US$100 million private placement of notes; establishment of a private shelf facility; and an amendment and extension to Air Lease’s unsecured revolving credit facility. Read
American Honda Finance Corporation
O’Melveny represented American Honda Finance Corporation (AHFC) in three public offerings of debt in 2015, raising aggregate gross proceeds in excess of US$3 billion and €1.2 billion of notes. Read
Case Study: Akeso Biopharma
O’Melveny advised Akeso Biopharma, a leading Chinese clinical-state biopharmaceutical company specializing in oncology and immunology therapies, in its listing and IPO on the Hong Kong Stock Exchange. Read
Case Study: Underwriters of Thermo Fisher Scientific Offering
O’Melveny represented Goldman Sachs & Co. LLC, as representative of the underwriters, in a registered public offering by Thermo Fisher Scientific Inc. of approximately US$1.7 billion of its common stock. Read
eHi Car Services
O’Melveny has represented Shanghai-based car rental company eHi Car Service for nearly a decade, advising the company on multiple growth financings, its US$120 million initial public offering on the NYSE, and, in 2018, on its management-led take-private for US$937.5 million. Read
LendingClub
O’Melveny represented the underwriters, led by Morgan Stanley & Co. LLC in the US$1 billion initial public offering of LendingClub Corporation (LendingClub) on the New York Stock Exchange. Read
LendingTree
O’Melveny represented the underwriters, led by Merrill Lynch, Pierce, Fenner & Smith Inc., RBC Capital Markets LLC and SunTrust Robinson Humphrey Inc., in connection with a US$112 million primary and secondary offering of shares of common stock of LendingTree Inc. Read
NextVR, Inc.
NextVR, an innovative technology company, turned to O’Melveny to help raise US$80 million in a Series B funding round to broadcast live events in virtual reality. Read
Yahoo!
O’Melveny represented Yahoo! Inc. in connection with a private placement of US$1.44 billion convertible senior notes. Read
Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.
